描述

Antibodies are proteins produced by the immune system in response to the introduction of a foreign body (known as an antigen). Antibodies have a variety of uses – in basic research, diagnostic tests and theraputics. As a cornerstone of the body’s immune response, antibodies can provide significant data to support scientists’ 研究. 根据StrategyHelix, the global research antibodies market is expected to increase by US$ 1,364.3 期间百万 2022-2028, 复合年增长率为 5.6% 在预测期内.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for research antibodies. The global research antibodies market is segmented on the basis of product, clonality, major reactivities, 技术, 最终用户, 和地区. 根据产品, the global research antibodies market is categorized into primary antibodies, secondary antibodies. The primary antibodies segment held the largest share of the global research antibodies market in 2021 预计在预测期内将持有其份额. On the basis of clonality, the global research antibodies market has been segmented into monoclonal antibodies, polyclonal antibodies. 全球范围, the polyclonal antibodies segment made up the largest share of the research antibodies market. By major reactivities, the global research antibodies market has been segmented into human, mouse, rat. The human segment was the largest contributor to the global research antibodies market in 2021. 以技术为基础, the global research antibodies market is categorized into enzyme-linked immunosorbent assay (ELISA), flow cytometry, immunofluorescent staining, immunohistochemistry, western blotting. 基于最终用户, the global research antibodies market has been segmented into pharma & biotech companies, academic and research institutions. 地理上, the global research antibodies market is segmented into Asia Pacific, 欧洲, 北美, 世界其他地区 (排).

The global research antibodies market is highly competitive. The prominent players operating in the global research antibodies market include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, Bio-Rad AbD Serotec GmbH, Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Santa Cruz Biotechnology Inc., Thermo Fisher Scientific Inc.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the research antibodies market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

产品: primary antibodies, secondary antibodies
Clonality: monoclonal antibodies, polyclonal antibodies
Major reactivities: human, mouse, rat
技术: enzyme-linked immunosorbent assay (ELISA), flow cytometry, immunofluorescent staining, immunohistochemistry, western blotting
最终用户: pharma & biotech companies, academic and research institutions
地区: 亚太地区, 欧洲, 北美, 世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2018 到 2028

利益相关者的主要好处

– Get a comprehensive picture of the global research antibodies market
– 根据当地数据确定区域战略和战略重点
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Research antibodies market overview
部分 3. 按产品划分的市场细分
– Primary antibodies
– Secondary antibodies
部分 4. Market breakdown by clonality
– Monoclonal antibodies
– Polyclonal antibodies
部分 5. Market breakdown by major reactivities
– Human
– Mouse
– Rat
部分 6. 按技术划分的市场细分
– Enzyme-linked immunosorbent assay (ELISA)
– Flow cytometry
– Immunofluorescent staining
– Immunohistochemistry
– Western blotting
部分 7. 按最终用户划分的市场细分
– Pharma & biotech companies
– Academic and research institutions
部分 8. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)
部分 9. 重点企业
– Abcam plc
– Agilent Technologies, 公司.
– Beckman Coulter Inc.
– Becton, Dickinson and Company
– Bio-Rad AbD Serotec GmbH
– Bio-Techne Corporation
– Cell Signaling Technology, 公司.
– F. Hoffmann-La Roche AG
– Merck KGaA
– Santa Cruz Biotechnology, 公司.
– Thermo Fisher Scientific Inc.
关于StrategyHelix
免责声明